Literature DB >> 3350963

Paradoxical glottic narrowing in patients with severe obstructive sleep apnea.

I Rubinstein1, A S Slutsky, N Zamel, V Hoffstein.   

Abstract

Most patients with obstructive sleep apnea have increased pharyngeal collapsibility (defined in the present study as an increased lung volume dependence of pharyngeal area), which predisposes them to upper airway occlusion during sleep. However, there are patients with severe obstructive sleep apnea who have low-normal pharyngeal collapsibility. The factors leading to nocturnal upper airway obstruction in such patients have not been ascertained. We studied 10 overweight male patients with severe obstructive sleep apnea and low-normal pharyngeal collapsibility to determine the site of upper airway pathology in these patients. We found that all 10 patients exhibited paradoxical inspiratory narrowing of the glottis during quiet tidal breathing. This phenomenon was not observed in a matched group of 10 snoring, nonapneic male controls. We conclude that paradoxical glottic narrowing may be a contributing factor in the pathogenesis of upper airway obstruction in patients with severe obstructive sleep apnea who have low-normal pharyngeal collapsibility.

Entities:  

Mesh:

Year:  1988        PMID: 3350963      PMCID: PMC329630          DOI: 10.1172/JCI113416

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Laryngeal abductor activity during sleep.

Authors:  J Orem; P Norris; R Lydic
Journal:  Chest       Date:  1978-02       Impact factor: 9.410

2.  Comparison of glottic areas measured by acoustic reflections vs. computerized tomography.

Authors:  A D D'Urzo; I Rubinstein; V G Lawson; K P Vassal; A S Rebuck; A S Slutsky; V Hoffstein
Journal:  J Appl Physiol (1985)       Date:  1988-01

3.  Effect of position and lung volume on upper airway geometry.

Authors:  J M Fouke; K P Strohl
Journal:  J Appl Physiol (1985)       Date:  1987-07

4.  Laryngeal regulation of respiratory airflow.

Authors:  D Bartlett; J E Remmers; H Gautier
Journal:  Respir Physiol       Date:  1973-07

5.  Respiratory EMG activity of the posterior cricoarytenoid, cricothyroid and diaphragm muscles during sleep.

Authors:  J H Sherrey; D Megirian
Journal:  Respir Physiol       Date:  1980-03

6.  Airway area by acoustic reflections measured at the mouth.

Authors:  J J Fredberg; M E Wohl; G M Glass; H L Dorkin
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-05

7.  Comparison of direct and acoustical area measurements in physical models of human central airways.

Authors:  A C Jackson; D E Olson
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-05

8.  Changes in pharyngeal cross-sectional area with posture and application of continuous positive airway pressure in patients with obstructive sleep apnea.

Authors:  I B Brown; P A McClean; R Boucher; N Zamel; V Hoffstein
Journal:  Am Rev Respir Dis       Date:  1987-09

9.  Airway area by acoustic response measurements and computerized tomography.

Authors:  A D D'Urzo; V G Lawson; K P Vassal; A S Rebuck; A S Slutsky; V Hoffstein
Journal:  Am Rev Respir Dis       Date:  1987-02

10.  Anatomic abnormalities in obstructive sleep apnea.

Authors:  D Wilms; J Popovich; W Conway; S Fujita; F Zorick
Journal:  Ann Otol Rhinol Laryngol       Date:  1982 Nov-Dec       Impact factor: 1.547

View more
  3 in total

1.  Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism).

Authors:  W S Mezzanotte; D J Tangel; D P White
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

Review 2.  Sleep-related breathing disorder.2. Pathophysiology of obstructive sleep apnoea.

Authors:  D P White
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

3.  Vocal cord dysfunction: an important differential diagnosis of bronchial asthma.

Authors:  Klaus Kenn; Markus M Hess
Journal:  Dtsch Arztebl Int       Date:  2008-10-10       Impact factor: 5.594

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.